Jianzhijia Pharmaceutical Chain Group Co., Ltd. (SHA:605266)
China flag China · Delayed Price · Currency is CNY
12.82
-0.31 (-2.36%)
Nov 18, 2026, 3:00 PM CST

SHA:605266 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
867.86878.58776.05857.93932.6983.1
Trading Asset Securities
16-50503-
Cash & Short-Term Investments
883.86878.58826.05907.93935.6983.1
Cash Growth
12.44%6.36%-9.02%-2.96%-4.83%-39.38%
Accounts Receivable
1,0011,059425.75440.48591.65227.87
Other Receivables
54.0950.1760.6856.9453.5456.96
Receivables
1,0561,110486.44497.42645.19284.83
Inventory
2,1422,1143,1282,3742,1661,121
Prepaid Expenses
-15.0414.0412.87--
Other Current Assets
236.16216.83228.09145.79192.89107.8
Total Current Assets
4,3184,3344,6833,9383,9392,497
Property, Plant & Equipment
2,1402,2832,5972,6872,6441,901
Long-Term Investments
19.1122.6130.5447.4218.349.8
Goodwill
2,4212,4212,4562,4032,243415.3
Other Intangible Assets
72.282.0185.3692.290.4644.75
Long-Term Deferred Tax Assets
291.65234.67280.17285.43287.2214.64
Long-Term Deferred Charges
290.77367.37485.3485.93415.89331.86
Other Long-Term Assets
13.398.946.0510.616.18-
Total Assets
9,5679,75410,6239,9499,6445,214

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
2,4122,2172,7832,6392,7561,695
Accrued Expenses
127.48202.29184.59216.07281.91105.3
Short-Term Debt
2,3611,9961,604749.61201.4830
Current Portion of Long-Term Debt
867.34283.55249.74572.5155.195.41
Current Portion of Leases
-522.42389.42423.84422.6378.41
Current Income Taxes Payable
107.2630.0819.7744.9366.8742.42
Current Unearned Revenue
2626.1625.2328.4937.4318.07
Other Current Liabilities
165.21103.45212.14185.57304.14146.67
Total Current Liabilities
6,0665,3815,4674,8604,2252,421
Long-Term Debt
642.63967.821,1901,0221,19225.23
Long-Term Leases
432.37509.13909.27927.52963.28842.93
Long-Term Unearned Revenue
10.7311.0611.5311.9612.6313.06
Long-Term Deferred Tax Liabilities
190.94213.28265.03282.25275.4419.03
Other Long-Term Liabilities
----407.82-
Total Liabilities
7,3437,0827,8437,1047,0763,321

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
154.54154.54156.66128.8599.1669.53
Additional Paid-In Capital
1,3381,3381,3971,3611,3911,009
Retained Earnings
879.271,3261,3411,3791,109856.89
Treasury Stock
-145.44-145.44-97.81-7.15-14.78-25.75
Comprehensive Income & Other
-1.08-0.240.12---
Total Common Equity
2,2252,6732,7972,8612,5851,910
Minority Interest
-1.4-1.31-16.68-16.51-16.59-16.72
Shareholders' Equity
2,2242,6722,7812,8452,5681,893
Total Liabilities & Equity
9,5679,75410,6239,9499,6445,214

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
4,3034,2794,3423,6962,9351,282
Net Cash (Debt)
-3,419-3,400-3,516-2,788-1,999-298.88
Net Cash Growth
------
Net Cash Per Share
-23.06-22.95-22.78-18.03-13.17-2.14
Filing Date Shares Outstanding
158.33148.16154.49154.62154.69141
Total Common Shares Outstanding
158.33148.16154.49154.62154.69141
Working Capital
-1,749-1,047-784.78-922.54-285.7876
Book Value Per Share
14.0518.0418.1118.5016.7113.54
Tangible Book Value
-268.52169.48255.83365.8251.511,450
Tangible Book Value Per Share
-1.701.141.662.371.6310.28
Buildings
-951.79906.25902.64891.8369.39
Machinery
-336.56312.13277.99225.09158.25
Construction In Progress
-194.17253.85202.01180.5673.91